Novartis ordered to sell eyecare product after Alcon acquisition
This article was originally published in Scrip
Executive Summary
The US Federal Trade Commission has ordered Novartis to sell its injectable miotic, Miochol-E (acetylcholine chloride) to Bausch & Lomb as part of a settlement to resolve complaints concerning the proposed acquisition of eyecare firm Alcon.